Kasvajavastased ravimid, immunosupressandid, oftalmoloogias kasutatavad ravimid, hingamisteede obstruktiivsete haiguste raviks kasutatavad ravimid, migreenivastased ravimid
Bid deadline
03.11.2026 17 days
Estimated value
26 513 000 €
Type
Supplies
Published
29.09.2026
Tender description
Kasvajavastaste ravimite, immunosupressantide, oftalmoloogias kasutatavate ravimite, hingamisteede obstruktiivsete haiguste raviks kasutatavate ravimite, migreenivastaste ravimite ostmine / Kõrvaldamise alused ja kvalifitseerimistingimused: Vaata hanke alusdokumentidest
Tender lots
43| Lot | Estimated value | Deadline |
|---|---|---|
| Panitumumab | 46 000 € | 03.11.2026 |
| Gemtuzumabosogamtsiin | 25 000 € | 03.11.2026 |
| Brentuksimabvedotiin | 400 000 € | 03.11.2026 |
| Pertuzumab | 380 000 € | 03.11.2026 |
| Trastuzumabemtansiin | 1 050 000 € | 03.11.2026 |
| Obinutuzumab | 500 000 € | 03.11.2026 |
| Nivolumab | 2 500 000 € | 03.11.2026 |
| Pembrolizumab | 3 500 000 € | 03.11.2026 |
| Blinatumomab | 100 000 € | 03.11.2026 |
| Daratumumab | 8 000 000 € | 03.11.2026 |
| Durvalumab | 500 000 € | 03.11.2026 |
| Atezolisumab | 1 600 000 € | 03.11.2026 |
| Tsemiplimab | 35 000 € | 03.11.2026 |
| Sugemalimab | 20 000 € | 03.11.2026 |
| Ipilimumab | 800 000 € | 03.11.2026 |
| Mogamulizumab | 100 000 € | 03.11.2026 |
| Enfortumabvedotiin | 180 000 € | 03.11.2026 |
| Teklistamab | 900 000 € | 03.11.2026 |
| Karfilsomiib | 250 000 € | 03.11.2026 |
| Iksasomiib | 100 000 € | 03.11.2026 |
| Pertuzumab + trastuzumab | 900 000 € | 03.11.2026 |
| Küüliku anti-T-lümfotsüütne immuunoglobuliin | 15 000 € | 03.11.2026 |
| Vedolizumab | 300 000 € | 03.11.2026 |
| Golimumab | 90 000 € | 03.11.2026 |
| Anakinra | 20 000 € | 03.11.2026 |
| Ustekinumab | 80 000 € | 03.11.2026 |
| Ustekinumab | 12 000 € | 03.11.2026 |
| Sekukinumab | 5000 € | 03.11.2026 |
| Sarilumab | 180 000 € | 03.11.2026 |
| Belimumab | 30 000 € | 03.11.2026 |
| Anifrolumab | 15 000 € | 03.11.2026 |
| Tsetuksimaab | 30 000 € | 03.11.2026 |
| Dostarlimab | 100 000 € | 03.11.2026 |
| Polatuzumabvedotiin | 800 000 € | 03.11.2026 |
| Trastuzumabderukstekaan | 800 000 € | 03.11.2026 |
| Mirikizumab | 80 000 € | 03.11.2026 |
| Glofitamab | 700 000 € | 03.11.2026 |
| Abatatsept | 90 000 € | 03.11.2026 |
| Guselkumab | 120 000 € | 03.11.2026 |
| Risankizumab | 200 000 € | 03.11.2026 |
| Avelumab | 300 000 € | 03.11.2026 |
| Ravulizumab | 600 000 € | 03.11.2026 |
| Omalizumab | 60 000 € | 03.11.2026 |
Similar open tenders
- Parenteraalsed toitelahusedOpen for bidsDeadline 20.10.2026 3 daysEstimated value 400 000 €Published 18.09.2026
- KlesrovimabOpen for bidsDeadline 20.10.2026 3 daysEstimated value 190 000 €Published 05.10.2026
- Puhasruumide desinfektsiooni- ja puhastusvahendidOpen for bidsDeadline 21.10.2026 4 daysPublished 17.09.2026
- Urogenitaalsüsteemi ravimid ja hormoonravimidOpen for bidsDeadline 23.10.2026 6 daysPublished 18.09.2026
- Ravim B01AB05 EnoksapariinOpen for bidsDeadline 27.10.2026 10 daysPublished 21.09.2026
- Kemoteraapias kasutatavad ravimidOpen for bidsDeadline 27.10.2026 10 daysPublished 22.09.2026
Source: Public Procurement Register open data. Amounts exclude VAT. The notice published in the Public Procurement Register is binding.